Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)

Exclusion Criteria

• •pregnant women or women in lactation
• •active HBV or HCV infection
• •HIV/AIDS infection
• •active infection
• •previously suffered from diseases or concurrent diseases as followed：
• •patients confirmed as severe autoimmune diseases in long-term (over 2 months) need of systemic immune inhibitors (steroid) or as immune-mediated symptomatic diseases including ulcerative colitis, Crohn's disease, rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune vasculitis (for example, Wegener's granulomatosis)
• •subjects with previous diagnosis as motor neurone disease caused by autoimmunity
• •subjects previously suffered from toxic epidermal necrolysis (TEN)
• •subjects with any mental diseases including dementia, mental status change that may impinge the understanding and performance of informed consent and related questionnaire
• •subjects with severe, uncontrollable diseases judged by investigators that may hinder them receiving this treatment
• •subjects with previously active malignant tumors including basal or squamous skin cancer, superficial bladder cancer, and in situ breast carcinoma within 5 years who had been completely cured without the need of follow-up treatment are not excluded.
• •during ongoing treatment using systemic steroid or steroid inhalants
• •subjects with unstable or active peptic ulcer or alimentary tract hemorrhage
• •subjects with previous organ transplantation or ready for organ transplantation
• •subjects in need of anticoagulant therapy treatment (warfarin or heparin)
• •subjects judged by investigators as not appropriate for this study